Allmedica Badania Kliniczne Sp. z o.o.
- Address
- lock Available on a paid plan
Digestive System Diseases
At Allmedica Badania Kliniczne Sp. z o.o. in Nowy Targ, much of the research focuses on digestive system diseases, especially Crohn’s disease, ulcerative colitis, and idiopathic or diabetic gastroparesis. These trials are designed to test new therapies and better understand how to improve symptom control, remission, and endoscopic healing in people with inflammatory bowel and gastrointestinal disorders.
- Studies in Crohn’s disease and ulcerative colitis evaluating whether new treatments can improve clinical remission and long-term disease control
- Research in inflammatory bowel disease aimed at finding better options for both induction and maintenance of response
- Trials in gastroparesis focused on easing delayed stomach emptying and related digestive symptoms
Overall, the site is contributing to research that may expand treatment choices for chronic gastrointestinal inflammation and other difficult-to-manage digestive conditions.
Immune System Diseases
This site is also active in immune system diseases, with a strong emphasis on moderately to severely active inflammatory bowel disease and related immune-mediated conditions. The trials are mainly evaluating whether new immunology-based treatments can reduce inflammation, maintain response, and improve day-to-day disease outcomes.
- Studies in ulcerative colitis and Crohn’s disease testing new approaches to control immune-driven intestinal inflammation
- Research in active psoriatic arthritis exploring therapies that may better manage joint inflammation and symptoms
- Trials assessing whether emerging immunomodulatory treatments can support both short-term improvement and longer-term maintenance
With multiple ongoing investigations, Allmedica Badania Kliniczne Sp. z o.o. is helping advance research into immune-related diseases where better control of inflammation remains a key goal.
Skin and Connective Tissue Diseases
Research in skin and connective tissue diseases at this site includes studies in atopic dermatitis and venous leg ulcer, reflecting interest in both chronic inflammatory skin conditions and complex wound healing. These trials are generally aimed at evaluating new treatments that may improve skin symptoms, support healing, and enhance quality of life.
- Trials in atopic dermatitis examining whether new therapies can reduce itching, redness, and overall disease severity
- Studies in venous leg ulcer focused on improving wound debridement and preparing the wound bed for healing
- Research into inflammatory skin disease looking for better symptom control and more durable treatment benefit
This area of work highlights the site’s broader role in testing treatments for chronic conditions that affect the skin, comfort, and healing.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 therapeutic areas and 15 of 17 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 11 by active trials.
lock +10 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +7 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Allmedica Badania Kliniczne Sp. z o.o.
lock Showing 1 of 28 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 1 Study of Afimkibart Effects on Cytochrome P450-Mediated Drug Metabolism in Patients With Active Ulcerative Colitis | F. Hoffmann-La Roche AG | Phase I | Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 17 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Duvakitug | 6 | Unknown | 2023-03-17 | 2026-07-22 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.